EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Glycoproteomics of body fluids and derived exosomes in hepatocellular carcinoma

Dongna Xie, Shengnan Jia, Nian Wang, Lianghai Hu

Advances in Clinical Chemistry · 2026

DOI: 10.1016/bs.acc.2026.01.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Clinical Chemistry, 2026. Verfasst von Dongna Xie und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Exosomes, Proteomics. Die Arbeit nennt 112 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC), a prevalent malignant tumor, is characterized by occult early symptoms, leading to most patients being diagnosed at advanced stages. This diagnostic delay significantly contributes to the high mortality and limited therapeutic efficacy observed in HCC. Therefore, the development and application of accurate early detection methods and efficacious treatment strategies are essential for improving patient survival and overall clinical outcomes. Glycoproteomics focuses on the characterization of glycosylation sites and site-specific glycans. As one of the most prevalent post-translational modifications of proteins, aberrant glycosylation plays a critical role in the initiation, progression, diagnosis and treatment of HCC. In-depth investigation of abnormal glycoproteins in HCC holds substantial scientific and clinical significance for unraveling its pathogenesis, identifying effective diagnostic biomarkers, and pinpointing potential therapeutic targets. Body fluids and the derived exosomes have emerged as a pivotal research frontier, owing to their distinctive advantages: non-invasiveness, a wealth of disease-associated information, and ease of collection. Based on this, this review elaborates on the research strategies of HCC glycoproteomics and provides a detailed description of the analysis of body fluids and derived exosomes, to explore potential biomarkers in the pathogenesis of HCC, thereby providing strong support for the early detection and personalized treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsExosomesProteomicsGlycoproteinsBody FluidsHumansBiomarkers, TumorGlycosylation

Stichwörter der Autor:innen

BiomarkerBody fluidsExosomesGlycosylationHepatocellular carcinomaMass spectrometryProteomics

Substanzen

GlycoproteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • School of Life Sciences, Jilin University, Changchun, China.
  • Department of Hepatopancreatobiliary Medicine, The Second Hospital, Jilin University, Changchun, China.
  • School of Life Sciences, Jilin University, Changchun, China; Center for Supramolecular Chemical Biology, State Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun, China. Electronic add…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xie, D., Jia, S., Wang, N., & Hu, L. (2026). Glycoproteomics of body fluids and derived exosomes in hepatocellular carcinoma. Advances in Clinical Chemistry. https://doi.org/10.1016/bs.acc.2026.01.001

Vancouver

Xie D, Jia S, Wang N, Hu L. Glycoproteomics of body fluids and derived exosomes in hepatocellular carcinoma. Advances in Clinical Chemistry. 2026. doi:10.1016/bs.acc.2026.01.001

BibTeX
@article{Xie2026,
  author = {Xie, Dongna and Jia, Shengnan and Wang, Nian and Hu, Lianghai},
  title = {Glycoproteomics of body fluids and derived exosomes in hepatocellular carcinoma},
  journal = {Advances in Clinical Chemistry},
  year = {2026},
  doi = {10.1016/bs.acc.2026.01.001}
}
Kostenlos starten →